Synapse - Nikoletta Lendvai

Nikoletta Lendvai

Lendvai_nikoletta

Groups

Hematologic Oncology Disease Management Team
Myeloma Disease Management Team
Hematologic Oncology, Division of
- Myeloma Service

Research Focus

Medicine; Assistant Attending

Recent additions – View all

A phase Ib dose escalation trial of sar650984 (anti-cd-38 mab) in combination with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma
Meeting Abstract

Martin, T.; Baz, R.; Benson, D.; Lendvai, N.; Vij, R.; more...
Haematologica (2014)

Fulltext@MSK | Save
A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma
Journal Article

Lendvai, N.; Hilden, P.; Devlin, S.; Landau, H.; Hassoun, H.; more...
Blood (2014)

Fulltext@MSK | Save
T-cell depleted allogeneic HSCT for patients with relapsed, high-risk multiple myeloma permits long-lasting remissions in the absence of graft-versus-host disease and provides a platform for adoptive immunotherapeutic approaches
Meeting Abstract

Koehne, G.; Devlin, S.; Landau, H.; Hassoun, H.; Lesokhin, A. M.; more...
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Co-authors at MSK

Types of Work

Publications

Blood (9)
Biology of Blood and Marrow Transplantation (5)
Bone Marrow Transplantation (2)
Haematologica (1)
Leukemia & Lymphoma (1)
Leukemia (1)